Delivery Order SPE2DB22D3401-SPE2DB25FT6HY
- Not listed
- On September 3, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,791.77 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,736.37 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract, executed on June 18, 2025, with an ultimate completion date of June 20, 2025, utilizes firm fixed price terms with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,958.79 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,008.18 firm fixed-price delivery order on August 25, 2025, for Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a non-set-aside contract with an ultimate completion date of August 26, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This delivery order, awarded September 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Oxcarbazepine 300 mg/5 ml suspension in a 250 ml quantity with a ceiling value of $1,125.28. The award is unset-aside and competitively awarded under a firm fixed price structure, with an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the...
- The Defense Logistics Agency awarded a delivery order valued at $1,155.65 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication commonly used in neurological treatment regimens. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The firm-fixed-price contract has a ceiling value of $1,324.26 and a completion date of April 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 150 mg tablets (100-count units) with a ceiling value of $2,169.26. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this qualified vendor. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $34.77K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine ER 600 mg tablets (100-count units) with an ultimate completion date of May 13, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,629.05 firm fixed-price delivery order is for the supply of 100 units of the medication OXCARBAZEPINE ER 600 MG TABLET. The contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6HYDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities, with a ceiling value of $1,216.72 and a firm fixed price structure. The delivery order is scheduled for completion by September 22, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs for defense and veteran healthcare systems, positioning it as a critical vendor in the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/19/25 |